Eligibility expansion for all people with type 1 diabetes to access subsidised CGM and Flash GM products through the NDSS Updated 27 June 2022 During the recent federal election campaign, the Government committed to provide subsidised access to continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) technology for all people living with type 1 diabetes. The rollout of this expansion will start on 1 July 2022. From this date, all people with type 1 diabetes will be able to apply for access to subsidised CGM and Flash GM products through the NDSS. From 1 July 2022, information will be available on the NDSS website to provide guidance for people with type 1 diabetes and health professionals. The process to apply for access to subsidised products will depend on whether a person has used CGM or Flash GM before (either accessed through the NDSS or directly from a product supplier). Diabetes Australia and the NDSS is available to assist and provide guidance for newly eligible people with type 1 diabetes about accessing subsidised CGM and Flash GM through the NDSS. Diabetes health professionals can provide assistance, education and training once the rollout commences.
